NEW YORK (GenomeWeb) – To help accelerate the clinical translation of insights gained from genome-wide association studies (GWAS) in type I diabetes, the National Institutes of Health this month announced that it has earmarked $15 million to fund efforts to characterize and validate genetic variations associated with the disease.

While a number of environmental factors play a role in the development of type I diabetes, a number of studies have also implicated genetics in the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.